SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Analysts and Calls -- Lehman

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who started this subject9/24/2002 11:14:43 AM
From: tuck  Read Replies (1) of 30
 
The specifics of today's call:

>>Transkaryotic TKTX Lehman Brothers Overweight

Millennium Pharm MLNM Lehman Brothers Equal-weight

MedImmune MEDI Lehman Brothers Overweight

IDEC Pharm IDPH Lehman Brothers Equal-weight

Human Genome HGSI Lehman Brothers Equal-weight

Gilead Sciences GILD Lehman Brothers Equal-weight

Genzyme GENZ Lehman Brothers Underweight

Genentech DNA Lehman Brothers Overweight

Chiron CHIR Lehman Brothers Underweight

Biogen BGEN Lehman Brothers Equal-weight

Amgen AMGN Lehman Brothers Overweight<<

Courtesy of Briefing.com again.

The call on MEDI is particularly brave or well informed: I believe it is today the an FDA advisory committee debates FluMist.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext